Galcanezumab is prescribed for:
- Migraine prevention
- Episodic cluster headache
- Neurologic headache disorders
Only CGRP inhibitor approved for cluster headache.
Generic Name: Galcanezumab-gnlm
Brand Names: Emgality
Galcanezumab is a CGRP inhibitor for migraine prevention and episodic cluster headache.
Galcanezumab is prescribed for:
Only CGRP inhibitor approved for cluster headache.
Common side effects:
Generally very well tolerated.
Galcanezumab is a monoclonal antibody that binds to CGRP for migraine and cluster headache prevention.
The only CGRP inhibitor approved for episodic cluster headache, providing a much-needed treatment option for this severe condition.
Loading dose of 240 mg initially, then 120 mg monthly.
For details, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Migraine is a debilitating neurological condition causing recurrent headaches with throbbing pain, nausea, and light/sound sensitivity, likely stemming from complex brain, nerve, and blood vessel interactions.
Osteoarthritis, a common degenerative joint disease, causes pain, stiffness, and reduced motion due to cartilage breakdown from aging, genetics, obesity, injuries, or repetitive stress.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Galcanezumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.